Replies to post #81550 on PharmaCyte Biotech Inc (PMCB)

[1234jklm]

Great reply

You are answering the latest in a series of posts which troll the company.

It was shown these posts didn’t even know how the ifosfamide was administered in our therapy or how the technology is applied for pancreatic cancer.

They thought it was injected into the arm where of course it would be activated by the liver before getting to the tumor.

This level of trolling doesn’t warrant replies imho.

[ace1234]

Good point about the financial crisis in 2008. A lot of companies went bankrupt at that time. I had not thought about this before.

[DragonBear]

You might remember 2008 there was a global financial crisis...their inability to secure more funds and bankruptcy doesn't necessarily have to do anything with their product...

So now we have Austrianova coming into existence 6 yrs after the German ad hoc research studies in 2004. And they go BK 4 yrs later because of the 2008 financial crisis??? Then it needs Nuvilex/PMCB a Microcrap scam for capital in 2011-2012.

As opposed to a biotech that incorporates in 2008, and staged a IPO late last yr, yielding $108M, and had favorable phase 2 results coming in last week.

Even if they intentionally prolong things..in the end, what are they going to do with all facilities and products? Just leave them there? Everything is pointing towards an IND and trial.

You are mixing up the fact Austrianova, per their website are not dependent on a mythical PMCB IND for their survival. Go to their website. They seem to have defined their niche, and it matters not how long Kenny keeps pumping the PMCB scam.

Regardless of circumstances, why would a better treatment for PC scare anyone?

Well, here's some more bad news for Kenny's PMCB Microcrap scam. While Kenny is pondering his next PR pump for CIAB, one of many better treatments coming for PC, was announced last week. A targeted therapy drug given in conjunction with a front line chemo drug, allowed the majority of the patients previously classified as non-operable, as becoming operable for PC tumor removal. The FDA has given the drug both orphan, and now accelerated approval. It's likely the EOY Phase 2 completion will graduate to Phase 3 sooner, than later.

The only "scare" to be had is what does Kenny PR after his pseudo-promise of an IND comes, and goes 31-Mar. Maybe the immuno therapy interim Phase 3 results from yet another "better treatment" in the pipeline will have reported by then(?).

Tick tick tick... only 3 weeks left before the mythical IND doesn't arrive.